Bioavailability of lenvatinib administered as a capsule or tablet in volunteers
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2014
At a glance
- Drugs Lenvatinib (Primary)
- Indications Endometrial cancer; Liver cancer; Lymphoma; Malignant melanoma; Non-small cell lung cancer; Renal cancer; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 19 Feb 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 19 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 19 Apr 2012 New trial record